# Studies of Insulin and Glucagon Action in the Liver

> **NCT07300982** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Duke University** · enrollment: 40 (estimated)

## Conditions studied

- Diabetes (DM)

## Interventions

- **DRUG:** Glucagon
- **DRUG:** Saline (placebo)

## Key facts

- **NCT ID:** NCT07300982
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2029-12
- **Final completion:** 2029-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07300982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07300982, "Studies of Insulin and Glucagon Action in the Liver". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07300982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
